Florescu AM, Lannov LV, Younis S, Cullum CK, et al. No wearing-off effect of erenumab or fremanezumab for chronic migraine prevention: a single-center, real-world, observational study. Cephalalgia 2024;44:3331024231222915.
PMID: 38215232